Cafneon OS 20mg Injection

Cafneon OS 20mg Injection belongs to a group of medicines known as methylxanthines. It is used to treat apnea of premature newborns. Apnea is a condition in which breathing is interrupted, causing abnormal heart rate and oxygen saturation changes. It is a common occurrence, particularly in premature infants.

Cafneon OS 20mg Injection contains 'Caffeine Citrate', which belongs to the central nervous system (CNS) stimulants class. This medicine stimulates the respiratory centre, sensitising it to hypercapnia. Thereby, Cafneon OS 20mg Injection effectively regulates the mean respiratory rate and tidal volume, improves pulmonary blood flow, and enhances the breathing pattern.

A paediatrician or healthcare professional will administer Cafneon OS 20mg Injection in a hospital setting. Cafneon OS 20mg Injection can cause side effects like a fast heartbeat, irregular heartbeat, and increased blood sugar levels. These side effects are not prevalent and vary from person to person. Consult your doctor if these symptoms continue or worsen.

Inform your doctor about the complete medical history of your infant. If you are nursing your infant and are being treated with this medication, avoid drinking coffee or using any other caffeine-containing products since caffeine passes into breast milk. This medication should be used with caution in infants with impaired hepatic or renal function. Before adjusting the dose, your doctor may assess your child's baseline serum caffeine levels if they were born to a mother who consumes caffeine.

Cafneon OS 20mg Injection is commonly used to treat apnea.

• Treat prematurity apnea:Caffeine citrate is most commonly used to treat premature infants, particularly those born preterm. Premature babies, particularly those born before 28 weeks of gestation, may experience pauses in breathing lasting more than 20 seconds (apnea). This is known as apnea of prematurity, and caffeine citrate is used to stimulate the respiratory centre in the brain, hence improving breathing and decreasing apnea episodes.
• Respiratory stimulation:Cafneon OS 20mg Injection works as a central respiratory stimulant, which means it can be beneficial in instances when respiratory function is limited, particularly in preterm infants with underdeveloped respiratory systems.
• Improvement of Diuresis:Caffeine is a moderate diuretic, but this is not the primary reason for its usage in therapeutic settings.
• Treatment for Neonatal Respiratory Depression:Caffeine citrate may be utilised in new borns with respiratory depression, particularly when it is associated with disorders such as hypoxia or birth asphyxia.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Cafneon OS 20mg Injection should be administered by a nurse or a doctor.
• Do not self-administer.

Inform your doctor about your infant's medical history. If you are breastfeeding and your infant is being treated with this medication, avoid drinking coffee or using any other caffeine-containing products since caffeine passes into breast milk. Cafneon OS 20mg Injection should only be used in a neonatal intensive care unit where adequate patient surveillance and monitoring facilities are available. Treatment should begin under the supervision of a neonatologist with experience in neonatal intensive care. This medication should be used with caution in infants with impaired liver or kidney function.